Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis
Compounded medications often experience fewer FSA coverage denials because they're not subject to insurance formulary restrictions that sometimes apply to brand-name drugs
While GLP-1 and GIP receptor activation primarily reduce energy intake through appetite suppression and delayed gastric emptying, glucagon receptor activation continues to drive energy expenditure through thermogenesis and hepatic fat oxidation regardless of whether caloric intake has already decreased
doi: 10.1038/ni.3133 19 KorneliusE.HuangJ
US$ 26.79
US$ 21.03
US$ 27.95
